Gene-specific Therapy
Gene-Specific Therapy is a therapeutic strategy within cystic fibrosis pharmacotherapy that targets the underlying genetic defect by correcting or compensating for the specific mutation in the CFTR gene, distinguishing it from symptomatic or organ-specific treatments.
132
Publications
8.2K
Citations
857
Authors
316
Institutions
Publications per year
2017–2026
30
132
Oligodeoxynucleotides as inhibitors of gene expression: a review.
C.A. Stein, Jack S. Cohen · PubMed · 1988 · 420 citations
1–5 of 132
857
4
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 857
316
Stanford University
Stanford, United States
4 h-index
5 publications
311 citations
University of Florida
Gainesville, United States
4 h-index
7 publications
353 citations
University of Michigan
Ann Arbor, United States
4 h-index
8 publications
1K citations
The University of Osaka
Osaka, Japan
4 h-index
17 publications
467 citations

University of Alabama at Birmingham
Birmingham, United States
4 h-index
14 publications
438 citations
Kyushu University
Fukuoka, Japan
3 h-index
21 publications
2.9K citations
Massachusetts General Hospital
Boston, United States
3 h-index
9 publications
339 citations
Fondazione Salvatore Maugeri
Pavia, Italy
3 h-index
24 publications
4.3K citations
1–8 of 316
Repository · 15 publications · 916 citations
14
h-index
5 publications · 466 citations
5
h-index
5 publications · 301 citations
5
h-index
4 publications · 271 citations
4
h-index
4 publications · 273 citations
4
h-index
1–5